Novavax
NVAX
#5100
Rank
HK$14.09 B
Marketcap
HK$85.39
Share price
1.02%
Change (1 day)
54.44%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : HK$8.98 Billion

According to Novavax's latest financial reports the company's total liabilities are HK$8.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$19.63 B-13.11%
2022-12-31HK$22.60 B-1.02%
2021-12-31HK$22.83 B208.35%
2020-12-31HK$7.40 B164.88%
2019-12-31HK$2.79 B-5.03%
2018-12-31HK$2.94 B-6.79%
2017-12-31HK$3.15 B1.86%
2016-12-31HK$3.10 B328.46%
2015-12-31HK$0.72 B101.15%
2014-12-31HK$0.35 B45.49%
2013-12-31HK$0.24 B44.33%
2012-12-31HK$0.17 B73.33%
2011-12-31HK$98.84 M-19.58%
2010-12-31HK$0.12 B1.27%
2009-12-31HK$0.12 B-49.56%
2008-12-31HK$0.24 B9.33%
2007-12-31HK$0.22 B1.51%
2006-12-31HK$0.21 B-19.48%
2005-12-31HK$0.26 B-22.5%
2004-12-31HK$0.34 B-7.03%
2003-12-31HK$0.37 B-3.05%
2002-12-31HK$0.38 B24.77%
2001-12-31HK$0.30 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
HK$624.05 B 6,842.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$906.77 B 9,988.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$513.32 B 5,610.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$554.76 B 6,071.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$13.02 B 44.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$0.53 B-94.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$2.96 B-66.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$9.33 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$7.93 B-11.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.08 B-32.36%๐Ÿ‡บ๐Ÿ‡ธ USA